Redeye: Isofol Medical - Knowledge is Power

Today we initiate coverage of biotech company Isofol Medical, that developing Modufolin, a new therapy used in the treatment of colorectal cancer and as a rescue therapy after high-dose chemotherapy treatment.

Continue reading at:

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.